You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萊美藥業(300006.SZ)子公司與信美保險社簽署合作框架協議 共同開發甲狀腺疾病相關保險產品
格隆匯 06-12 20:55

格隆匯6月12日丨萊美藥業(300006.SZ)公佈,公司子公司北京藍天共享健康管理有限責任公司(“藍天共享”、“乙方”)與信美人壽相互保險社(“信美保險社”、“甲方”)簽署了《合作框架協議》,該協議的簽署確立了雙方合作的夥伴關係,為雙方推進具體項目合作奠定了基礎,但雙方後續的合作以具體簽訂的協議為準,具體的實施內容和進度尚存在不確定性。

信美保險社系國內成立的相互人壽保險組織,擁有實力雄厚的出資人和先進的互聯網運營和管理理念。信美保險社主要聚焦於同質風險保障需求的單位或個人,着力發展長期養老和健康保障業務,積極開展普惠金融和共享經濟的實踐探索,努力為保險行業發展注入新活力。

藍天共享系公司子公司,致力於成為國內甲狀腺疾病細分領域的引導者。藍天共享依託公司核心產品卡納琳在甲狀腺領域市場優勢地位,一方面拓展甲狀腺專業化產品矩陣,另一方面通過甲狀腺專業學術機構,搭建線上線下相結合的專業化甲狀腺疾病管理體系。

甲乙雙方在中國甲狀腺疾病健康管理領域建立戰略合作伙伴關係,推動雙方合作共贏。在甲狀腺疾病健康管理領域,雙方利用各自優勢,通過保險產品、創新疾病管理模式,共同為甲狀腺疾病相關人羣提供更優的保險保障及更專業、精細化的健康管理服務。

藍天共享與信美保險社簽訂框架協議,充分發揮雙方在各自領域的資源優勢,共同合作開發具有市場競爭力的甲狀腺疾病相關保險產品,在甲狀腺疾病健康管理領域,通過保險產品、創新疾病管理模式,共同為甲狀腺疾病相關人羣提供更優質的保險保障及更專業、精細化的健康管理服務,有利於推動公司打造甲狀腺疾病領域頭部企業戰略目標的實現。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account